Fluorescent in situ hybridization studies in multiple myeloma

Area of Science:

• Hematology
• Oncology
• Cytogenetics

Background:

• Multiple myeloma (MM) is a hematologic malignancy characterized by uncontrolled proliferation of plasma cells.
• Accurate diagnosis and risk stratification are crucial for effective MM patient management.
• Cytogenetic abnormalities play a significant role in MM prognosis.

Purpose of the Study:

• To evaluate the utility of conventional cytogenetics and fluorescence in situ hybridization (FISH) in identifying chromosomal abnormalities at MM diagnosis.
• To determine the frequency of specific genetic alterations, including 13q deletion, 14q32 rearrangement, and 17p deletion, in MM patients.
• To assess the clinical significance of these findings for patient follow-up.

Main Methods:

• Bone marrow samples from 36 newly diagnosed MM patients were analyzed.
• Conventional cytogenetic analysis was performed.
• Fluorescence in situ hybridization (FISH) was employed using probes for 13q (RB1, D13S319, D13S25), 14q32 (IgH), and 17p13 (p53).

Main Results:

• Conventional cytogenetics revealed normal karyotypes in 55.5% of patients, with chromosomal abnormalities in 22.2%.
• FISH analysis detected at least one abnormality in 69.5% of cases.
• 14q32 rearrangement was the most frequent finding (58.3%), followed by 13q deletion (30.5%) and 17p deletion (13.9%).

Conclusions:

• FISH analysis is highly effective in detecting clinically relevant chromosomal abnormalities in MM.
• 14q32 rearrangement is a common genetic alteration in MM.
• FISH studies focusing on 14q32 and 17p13 regions offer significant value for clinical monitoring of MM patients.